Chris Stevens – Chief Executive Officer & Executive Director – Coda Minerals (ASX:COD) is an advanced exploration company primed to unlock the value of the highly prospective Elizabeth Creek Copper Cobalt Project in South Australia’s world class mining jurisdiction, the Gawler Craton.
Copyright 2024 – Finance News Network
Source: Finance News Network
03 Feb 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook provides an update on the company's record December quarter results, progress with strategic partners and overseas expansion plans.
Read More28 Feb 2020 - Washington H. Soul Pattinson and Company Limited (ASX:SOL) Managing Director, Todd Barlow provides a portfolio update and talks about the approach to investment that has enabled the company to outperform over decades.
Read More12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the company's new Phase 2 trial in soft tissue sarcoma and the outlook ahead.
Read More22 Nov 2022 - Radiopharmaceutical Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapies.
Read More28 Aug 2019 - Noxopharm Limited (ASX:NOX) CEO Dr Greg van Wyk discusses the company's anti-prostate cancer drug Veyonda, its efficacy in prostate cancer treatment, the drug’s upside and the company’s strategy for growth.
Read More07 Jul 2021 - Knosys Limited (ASX:KNO Managing Director John Thompson provides an overview of the recent acquisition of LIBERO, a leading library management software business.
Read More14 Oct 2024 - Hiremii Limited (ASX:HMI) Managing Director and CEO Andrew Hornby discusses revolutionising recruitment through AI integration, touching on the company's revenue growth, international expansion, and opportunities in the resources and energy sectors.
Read More30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the company's LAG-3-related therapies, outlining future plans and expected data readouts for Immutep's lead drug, eftilagimod alpha.
Read More27 May 2022 - TerraCom Limited (ASX:TER) Executive Chairman Craig Ransley discusses drivers behind the company's performance and share price over the previous year.
Read More21 Dec 2023 - Dive into Laramide Resources' (ASX:LAM) uranium ventures with insights from Non-Executive Chairman John G Booth. He discusses flagship projects, grants and developments in Australia and the US.
Read More
